← Back to all trials
Recruiting
NCT07664228
I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis
Conditions: IgA Vasculitis, Gastrointestinal Involvement
Sex: All
Ages: 2 Years – 18 Years
Healthy volunteers: No
Enrollment: 100
Sponsor: Bursa City Hospital
Location: Bursa City Hospital Bursa Bursa
Summary
This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of IgA vasculitis (Henoch-Schönlein purpura) according to EULAR/PRINTO/PRES classification criteria.
* Age between 2 and 18 years.
* Availability for blood sample collection at diagnosis (baseline visit).
* Ability to attend a routine follow-up visit approximately 2-4 weeks after diagnosis.
* Parent or legal guardian able and willing to provide written informed consent.
Exclusion Criteria:
* Refusal of informed consent by the parent/legal guardian.
* Inability to obtain a baseline blood sample.
* Inability to complete study follow-up procedures.
Source: ClinicalTrials.gov (NCT07664228). StuddyBuddy aggregates publicly available trial information.